MRI Contrast Media Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers

What industry-specific factors are fueling the growth of the mri contrast media market?
The increase in cancer incidences is anticipated to drive the expansion of the MRI contrast media market in the future. The surge in cancer incidences can be attributed to a complex mix of demographic, lifestyle, environmental, genetic, and healthcare-related factors. Gadolinium-based compounds used in contrast agents during MRI scans improve the images by changing the magnetic properties of tissues, which supports the identification, measurement, and description of tumors, as well as the evaluation of their spread into nearby tissues. For example, a report by the World Health Organization (WHO), a Switzerland-based intergovernmental group, stated in February 2024 that by 2022, the global projected number of new cancer cases hit 20 million, responsible for 9.7 million fatalities. These estimates predict a noteworthy surge in cancer incidences by 2050, with above 35 million new cases expected, showing a 77% growth from the projected 20 million cases in 2022. As a result, the surge in cancer incidences is fueling the expansion of the MRI contrast media market.

Get Your MRI Contrast Media Market Report Here:
https://www.thebusinessresearchcompany.com/report/mri-contrast-media-global-market-report

What Is the projected market size and growth rate for the mri contrast media market?
In recent times, there has been a significant upsurge in the size of the MRI contrast media market. It is predicted to inflate from $1.56 billion in 2024 to $1.66 billion in 2025 with a Compound Annual Growth Rate (CAGR) of 6.4%. Several factors contribute to this historical growth, including the escalating need for early detection, greater demand for diagnostic precision and better patient outcomes, heightened public awareness, the evolution of combined imaging procedures, and discovery of innovative applications for contrast agents.

A robust augment is expected in the MRI contrast media market size in the upcoming years, with projections reaching $2.11 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.1%. The escalation in the projection period can be credited to the rising incidence of cancer, mounting prevalence of lasting diseases, uptick in research and development activities and investment, hikes in healthcare costs, and the broadening use of MRI. Significant trends in the projection period encompasses advancements through collaborative research, technological evolution, product originality, creating safer and more effective contrast agents, and product breakthroughs from pharmaceutical and biotechnology businesses.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14964&type=smp

What new trends are reshaping the mri contrast media market and its opportunities?
Leading businesses in the MRI contrast media market are concentrating on the creation and distribution of innovative products, such as macrocyclic gadolinium-based contrast agents (GBCA), to increase the safety and diagnostic ability of MRI imaging procedures. Macrocyclic gadolinium-based contrast agent (GBCA), a type of contrast agent, is primarily utilized in magnetic resonance imaging (MRI). As an example, Guerbet, a company based in France specializing in MRI contrast media, introduced Elucirem (gadopiclenol) injection in February 2023. The Elucirem (gadopiclenol) injection is unique due to its highly stable macrocyclic gadolinium-based contrast agent (GBCA), which boasts the highest relaxivity in its class for MRI. The novel gadopiclenol formulation is especially remarkable for its capacity to identify and display lesions with unusual vascularity in various areas of the central nervous system (including the brain, spine, and associated tissues), as well as the body (which includes the head and neck, thorax, abdomen, pelvis, and the musculoskeletal system).

What major market segments define the scope and growth of the mri contrast media market?
The mri contrast media market covered in this report is segmented -

1) By Product: Extracellular Contrast Agents, Blood-Pool Agent, Hepatobiliary Agents
2) By Application: Neurological Disorders, Musculoskeletal Disorders, Cardiovascular Disorders, Cancer Detection, Other Applications
3) By End-User: Hospitals, Diagnostic And Imaging Centers, Research Institutes, Other End Users

Subsegments:
1) By Extracellular Contrast Agents: Gadolinium-Based Contrast Agents (GBCA), Non-Gadolinium-Based Contrast Agents
2) By Blood-Pool Agent: Macromolecular Agents, Nanoparticle-Based Agents
3) By Hepatobiliary Agents: Hepatocyte-Specific Agents, Biliary-Specific Agents

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14964

Which region dominates the mri contrast media market?
North America was the largest region in the MRI contrast media market in 2024. The regions covered in the MRI contrast media market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which key market leaders are driving the mri contrast media industry growth?
Major companies operating in the MRI contrast media market are Bayer AG, GE Healthcare Technologies Inc., Fresenius Kabi AG, Fujifilm Holdings Corporation, JB Chemicals and Pharmaceuticals Ltd., Jiangsu Hengrui Pharmaceutical Co. Ltd., Bracco S.p.A., Miltenyi Biotec B.V. & Co. KG, Lantheus Medical Imaging Inc., Guerbet LLC, Curium Pharma, Spago Nanomedical AB, AMAG Pharmaceuticals Inc., Nanopet Pharma GmbH, Trivitron Healthcare, Beijing Beilu Pharmaceuticals Company Limited, Unijules Life Sciences Ltd., Taejoon Pharm Co. Ltd., Mediso USA LLC, Nano Therapeutics Pvt. Ltd., Livealth Biopharma Pvt Ltd., BioPAL Inc., Vitalquan LLC, Shubhra Biotech Pvt Ltd., Rege Imaging & Cine Films Private Limited, Polarean Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=14964&type=smp

What Is Covered In The MRI Contrast Media Global Market Report?

•Market Size Forecast: Examine the mri contrast media market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the mri contrast media market for a structured understanding.
•Key Players Overview: Analyze major players in the mri contrast media market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the mri contrast media market.
•Segment Contributions: Evaluate how different segments drive overall growth in the mri contrast media market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the mri contrast media market.
•Industry Challenges: Identify potential risks and obstacles affecting the mri contrast media market.
•Competitive Landscape: Review strategic developments in the mri contrast media market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.